The first investigation started May 10, when police received a complaint regarding an April incident.
âDetectives learned through the family members of the victim, 79-year-old John Furman, that in early April, while in the care of this facility, he was found on the floor after suffering from a fall,â the release stated. âAs a result of this fall, the victim suffered a laceration to his head and massive bruising to his face.â
Employees reported Furmanâs fall and injuries to the centerâs manager, Katrina Perkins, and its director, Jeffrey Smith. However, according to the release, âBoth the director and manager to this facility failed to notify EMS or the victimâs family. Due to these injuries, the victimâs health started to decline rapidly; however, family members were unaware and not allowed to visit him due to COVID-19 restrictions.
After months of restrictions to slow the spread of COVID-19, new vaccines may soon offer a return to normalcy. After encouraging trial data, Pfizer and Moderna have both applied for emergency use authorization from the Food and Drug Administration for their respective vaccines, and the Pfizer-BioNTech vaccine was granted emergency authorization Friday night. Now, the focus shifts to distribution.
The FDA grants emergency use authorization to allow an unapproved medical product to be used in a public health emergency when there are no approved and available alternatives.
The vaccine will cause some distribution challenges. For example, the Pfizer vaccine must be stored at minus 70 degrees Celsius, and both vaccines must be given in two separate doses. One dose of the Pfizer vaccine is about 52% effective, whereas two doses are 95% effective. There is also no evidence that the protection from one dose lasts more than a few weeks without the second dosage.
On his way out of the White House, President Donald Trump is taking one last swipe at the Affordable Care Act, proposing to allow states to opt out of the Obamacare exchanges where millions of America.